Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease

Journal of Immunology

Volumn 182, Issue 2, 2009, Pages 934-947

  Lin, Gloria H Y ^a   Sedgmen, Bradley J ^a,c   Moraes, Theo J ^a   Snell, Laura M ^a   Topham, David J ^b   Watts, Tania H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c CSL LIMITED   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; CD137 LIGAND; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; EFFECTOR CELL; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS LOAD; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INTRANASAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MORTALITY; MOUSE MUTANT; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; VIROLOGY; VIRULENCE; VIRUS PNEUMONIA;

4-1BB LIGAND; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, CD137; EPITOPES, T-LYMPHOCYTE; GENE EXPRESSION REGULATION; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; VIRULENCE;

EID: 60549117865     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.2.934     Document Type: Article

References (72)

1. Wong, P., and E. G. Pamer. 2003. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 21: 29-70.
2. Thomas, P. G., R. Keating, D. J. Hulse-Post, and P. C. Doherty. 2006. Cellmediated protection in influenza infection. Emerg. Infect. Dis. 12: 48-54.
3. Doherty, P. C., S. J. Turner, R. G. Webby, and P. G. Thomas. 2006. Influenza and the challenge for immunology. Nat. Immunol. 7: 449-455.
4. + cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 188: 223-232.
5. Humphreys, I. R., G. Walzl, L. Edwards, A. Rae, S. Hill, and T. Hussell. 2003. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J. Exp. Med. 198: 1237-1242.
6. Wissinger, E., J. Sladana, A. Didierlaurent, and T. Hussell. 2008. Manipulation of acute inflammatory lung disease. Mucosal Immunology 1: 265-278.
7. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165: 6833-6839.
8. + T-cell memory. Immunol. Rev. 211: 67-80.
9. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068.
10. + T cells. Immunol. Rev. 211: 81-92.
11. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
12. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245.
13. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
14. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
15. Watts, T. H., and M. A. DeBenedette. 1999. T cell costimulatory molecules other than CD28. Curr. Opin. Immunol. 11: 286-293.
16. Kwon, B. S., and S. M. Weismann. 1989. cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 86: 1963-1967.
17. Vinay, D. S., and B. S. Kwon. 1998. Role of 4-1BB in immune responses. Semin. Immunol. 10: 481-489.
18. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620.
19. Dawicki, W., and T. H. Watts. 2004. Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo. Eur. J. Immunol. 34: 743-751.
20. Bertram, E. M., W. Dawicki, B. Sedgmen, J. L. Bramson, D. H. Lynch, and T. H. Watts. 2004. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. J. Immunol. 172: 981-988.
21. + T cell responses. Nat. Immunol. 3: 536-541.
22. Melero, I., W. W. Shuford, S. A. Newby, A. Aruffo, J. A. Ledbetter, K. E. Hellstrom, R. S. Mittler, and L. Chen. 1997. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3: 682-685.
23. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186: 47-55.
24. Takahashi, C., R. S. Mittler, and A. T. Vella. 1999. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162: 5037-5040.
25. Bertram, E. M., P. Lau, and T. H. Watts. 2002. Temporal segregation of CD28 versus 4-1BBL-mediated costimulation: 4-1BBL influences T cell numbers late in the primary response and regulates the size of the memory response following influenza infection. J. Immunol. 168: 3777-3785.
26. Pulle, G., M. Vidric, and T. H. Watts. 2006. IL-15-dependent induction of 4-1BB promotes Ag-independent CD8 memory T cell survival. J. Immunol. 176: 2739-2748.
27. DeBenedette, M. A., T. Wen, M. F. Bachmann, P. S. Ohashi, B. H. Barber, K. L. Stocking, J. J. Peschon, and T. H. Watts. 1999. Analysis of 4-1BB ligand-deficient mice and of mice lacking both 4-1BB ligand and CD28 reveals a role for 4-1BB ligand in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol. 163: 4833-4841.
28. Tan, J. T., J. K. Whitmire, R. Ahmed, T. C. Pearson, and C. P. Larsen. 1999. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. 163: 4859-4868.
29. Ray, S. J., S. N. Franki, R. H. Pierce, S. Dimitrova, V. Koteliansky, A. G. Sprague, P. C. Doherty, A. R. de Fougerolles, and D. J. Topham. 2004. The collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20: 167-179.
30. + T cell immunodominance hierarchies when antigen is limiting. J. Immunol. 177: 2917-2925.
31. Cottey, R., C. A. Rowe, and B. S. Bender. 2001. Measurement of tissue culture influenza virus infectious dose. In Current Protocols in Immunology, Vol. 4. John Wiley and Sons, p. 9.11.11.
32. Bett, A. J., W. Haddara, L. Prevec, and F. L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91: 8802-8806.
33. Bukczynski, J., T. Wen, K. Ellefsen, J. Gauldie, and T. H. Watts. 2004. Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 101: 1291-1296.
34. Salazar, E., and J. H. Knowles. 1964. An analysis of pressure-volume characteristics of the lungs. J. Appl. Physiol. 19: 97-104.
35. Ennis, F. A., M. Verbonitz, P. Reichelderfer, and S. Daniel. 1976. Recombination of influenza A virus strains: effect on pathogenicity. Dev. Biol. Stand. 33: 220-225.
36. + T cells. J. Immunol. 144: 3980-3986.
37. Effros, R. B., P. C. Doherty, W. Gerhard, and J. Bennink. 1977. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J. Exp. Med. 145: 557-568.
38. Bonville, C. A., N. J. Bennett, M. Koehnlein, D. M. Haines, J. A. Ellis, A. M. DelVecchio, H. F. Rosenberg, and J. B. Domachowske. 2006. Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology 349: 87-95.
39. Hussell, T., A. Pennycook, and P. J. Openshaw. 2001. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur. J. Immunol. 31: 2566-2573.
40. Thatte, J., V. Dabak, M. B. Williams, T. J. Braciale, and K. Ley. 2003. LFA-1 is required for retention of effector CD8 T cells in mouse lungs. Blood 101: 4916-4922.
41. Pollok, K. E., Y.-J. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T. Pickard, and B. S. Kwon. 1993. Inducible T cell antigen 4-1BB: analysis of expression and function. J. Immunol. 150: 771-781.
42. Doherty, P. C., and J. P. Christensen. 2000. Accessing complexity: the dynamics of virus-specific T cell responses. Annu. Rev. Immunol. 18: 561-592.
43. Salih, H. R., H. M. Schmetzer, C. Burke, G. C. Starling, R. Dunn, R. Pelka-Fleischer, V. Nuessler, and P. A. Kiener. 2001. Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies. J. Immunol. 167: 4059-4066.
44. Arch, R. H., and C. B. Thompson. 1998. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kB. Mol. Cell Biol. 18: 558-565.
45. L and Bfl-1. J. Immunol. 169: 4882-4888.
46. Wang, C., T. Wen, J. P. Routy, N. F. Bernard, R. P. Sekaly, and T. H. Watts. 2007. 4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells. J. Immunol. 179: 8252-8263.
47. Sabbagh, L., G. Pulle, Y. Liu, E. N. Tsitsikov, and T. H. Watts. 2008. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo. J. Immunol. 180: 8093-8101.
48. Niu, L., S. Strahotin, B. Hewes, B. Zhang, Y. Zhang, D. Archer, T. Spencer, D. Dillehay, B. Kwon, L. Chen, A. T. Vella, and R. S. Mittler. 2007. Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J. Immunol. 178: 4194-4213.
49. Hurtado, J. C., Y. J. Kim, and B. S. Kwon. 1997. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol. 158: 2600-2609.
50. Green, D. R. 2008. Fas Bim boom! Immunity 28: 141-143.
51. Langstein, J., J. Michel, J. Fritsche, M. Kreutz, R. Andreesen, and H. Schwarz. 1998. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160: 2488-2494.
52. Langstein, J., and H. Schwarz. 1999. Identification of CD137 as a potent monocyte survival factor. J. Leukocyte Biol. 65: 829-833.
53. + cells by CD137 ligand signaling. Stem Cells 26: 2372-2381.
54. Lee, S. W., Y. Park, T. So, B. S. Kwon, H. Cheroutre, R. S. Mittler, and M. Croft. 2008. Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat. Immunol. 9: 917-926.
55. Futagawa, T., H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, H. Yagita, and K. Okumura. 2002. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol. 14: 275-286.
56. Brehm, M. A., K. A. Daniels, and R. M. Welsh. 2005. Rapid production of TNF-α following TCR engagement of naive CD8 T cells. J. Immunol. 175: 5043-5049.
57. Zhang, B., C. H. Maris, J. Foell, J. Whitmire, L. Niu, J. Song, B. S. Kwon, A. T. Vella, R. Ahmed, J. Jacob, and R. S. Mittler. 2007. Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J. Clin. Invest. 117: 3029-3041.
58. Arens, R., K. Tesselaar, P. A. Baars, G. M. van Schijndel, J. Hendriks, S. T. Pals, P. Krimpenfort, J. Borst, M. H. van Oers, and R. A. van Lier. 2001. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion. Immunity 15: 801-812.
59. Tesselaar, K., R. Arens, G. M. van Schijndel, P. A. Baars, M. A. van der Valk, J. Borst, M. H. van Oers, and R. A. van Lier. 2003. Lethal T cell immunodefi-ciency induced by chronic costimulation via CD27-CD70 interactions. Nat. Immunol. 4: 49-54.
60. Tesselaar, K., Y. Xiao, R. Arens, G. M. van Schijndel, D. H. Schuurhuis, R. E. Mebius, J. Borst, and R. A. van Lier. 2003. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170: 33-40.
61. + memory T cells and their capacity for secondary expansion. J. Immunol. 175: 1665-1676.
62. b-restricted epitope from two different strains of influenza virus nucleoprotein. J. Gen. Virol. 82: 1069-1074.
63. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrang, B. Ecabert, B. Odermatt, and M. F. Bachmann. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity 11: 699-708.
64. Hendriks, J., L. A. Gravestein, K. Tesselaar, R. A. W. van Lier, T. N. M. Schumacher, and J. Borst. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1: 433-440.
65. Hendriks, J., Y. Xiao, and J. Borst. 2003. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198: 1369-1380.
66. Lyons, P. A., W. W. Hancock, P. Denny, C. J. Lord, N. J. Hill, N. Armitage, T. Siegmund, J. A. Todd, M. S. Phillips, J. F. Hess, S. L. Chen, et al. 2000. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 13: 107-115.
67. Cannons, J. L., G. Chamberlain, J. Howson, L. J. Smink, J. A. Todd, L. B. Peterson, L. S. Wicker, and T. H. Watts. 2005. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes. J. Autoimmun. 25: 13-20.
68. Maier, L. M., D. J. Smyth, A. Vella, F. Payne, J. D. Cooper, R. Pask, C. Lowe, J. Hulme, L. J. Smink, H. Fraser, et al. 2005. Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes. BMC Genet. 6: 9.
69. Townsend, A. R., J. Rothbard, F. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959-968.
70. Chen, W., P. A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O'Neill, J. Schickli, P. Palese, et al. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7: 1306-1312.
71. Vitiello, A., L. Yuan, R. W. Chesnut, J. Sidney, S. Southwood, P. Farness, M. R. Jackson, P. A. Peterson, and A. Sette. 1996. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J. Immunol. 157: 5555-5562.
72. Belz, G. T., W. Xie, and P. C. Doherty. 2001. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses. J. Immunol. 166: 4627-4633.